Literature DB >> 24079680

The necessity for clinical reasoning in the era of evidence-based medicine.

Allan D Sniderman1, Kevin J LaChapelle, Nikodem A Rachon, Curt D Furberg.   

Abstract

Clinical decisions are increasingly driven by evidence-based recommendations of guideline groups, which aim to be based on the highest quality knowledge-randomized clinical trials (RCTs) and meta-analyses. Although RCTs provide the best assessment of the overall value of a therapy, high-quality evidence from RCTs is often incomplete, contradictory, or absent even in areas that have been most exhaustively studied. Moreover, the likelihood of the success or failure of a therapy is not identical in all the individuals treated in any trial because therapy is not the only determinant of outcome. Therefore, the overall results of a trial cannot be assumed to apply to any particular individual, not even someone who corresponds to all the entry criteria for the trial. In addition, the potential for bias due to financial conflicts remains in many guideline groups. Guidelines are key sources of knowledge. Nevertheless, limitations in the extent, quality, generalizability, and transferability of evidence mean that we clinicians must still reason through the best choices for an individual because even in the absence of full and secure knowledge, clinical decisions must still be made. Clinical reasoning is the pragmatic, tried-and-true process of expert clinical problem solving that does value mechanistic reasoning and clinical experience as well as RCTs and observational studies. Clinicians must continue to value clinical reasoning if our aim is the best clinical care for all the individuals we treat.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Keywords:  EBM; LDL; RCT; evidence-based medicine; low-density lipoprotein; randomized clinical trial

Mesh:

Substances:

Year:  2013        PMID: 24079680     DOI: 10.1016/j.mayocp.2013.07.012

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  15 in total

1.  Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity.

Authors:  Mary Eapen; Ruta Brazauskas; Michael Hemmer; Waleska S Perez; Patricia Steinert; Mary M Horowitz; H Joachim Deeg
Journal:  Blood Adv       Date:  2018-08-28

2.  Response to Letter to the Editor, Regarding Hardcastle TC, Muckart DJJ, Maier RV. Ventilation in Trauma Patients: The First 24 h is Different! World Journal of Surgery 2017;41(5):1153-1158.

Authors:  Timothy Hardcastle
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

3.  Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.

Authors:  Mary Eapen; Joanne Kurtzberg; Mei-Jie Zhang; Gareth Hattersely; Mingwei Fei; Adam Mendizabal; Ka Wah Chan; Satiro De Oliveira; Kirk R Schultz; Donna Wall; Mary M Horowitz; John E Wagner
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-03       Impact factor: 5.742

4.  Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.

Authors:  Paul V O'Donnell; Claudio G Brunstein; Ephraim J Fuchs; Mei-Jie Zhang; Mariam Allbee-Johnson; Joseph H Antin; Eric S Leifer; Hany Elmariah; Michael R Grunwald; Hamza Hashmi; Mary M Horowitz; John M Magenau; Navneet Majhail; Filippo Milano; Lawrence E Morris; Andrew R Rezvani; Joseph P McGuirk; Richard J Jones; Mary Eapen
Journal:  Transplant Cell Ther       Date:  2021-11-11

5.  Development of a clinical polygenic risk score assay and reporting workflow.

Authors:  Jason L Vassy; Matthew S Lebo; Limin Hao; Peter Kraft; Gabriel F Berriz; Elizabeth D Hynes; Christopher Koch; Prathik Korategere V Kumar; Shruti S Parpattedar; Marcie Steeves; Wanfeng Yu; Ashley A Antwi; Charles A Brunette; Morgan Danowski; Manish K Gala; Robert C Green; Natalie E Jones; Anna C F Lewis; Steven A Lubitz; Pradeep Natarajan
Journal:  Nat Med       Date:  2022-04-18       Impact factor: 87.241

6.  Evidence in clinical reasoning: a computational linguistics analysis of 789,712 medical case summaries 1983-2012.

Authors:  Bastian M Seidel; Steven Campbell; Erica Bell
Journal:  BMC Med Inform Decis Mak       Date:  2015-03-21       Impact factor: 2.796

7.  A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.

Authors:  Tessa Kennedy-Martin; Sarah Curtis; Douglas Faries; Susan Robinson; Joseph Johnston
Journal:  Trials       Date:  2015-11-03       Impact factor: 2.279

8.  Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trials.

Authors:  George Thanassoulis; Ken Williams; Keying Ye; Robert Brook; Patrick Couture; Patrick R Lawler; Jacqueline de Graaf; Curt D Furberg; Allan Sniderman
Journal:  J Am Heart Assoc       Date:  2014-04-14       Impact factor: 5.501

Review 9.  Clinician's guide to the updated ABCs of cardiovascular disease prevention.

Authors:  Payal Kohli; Seamus P Whelton; Steven Hsu; Clyde W Yancy; Neil J Stone; Jonathan Chrispin; Nisha A Gilotra; Brian Houston; M Dominique Ashen; Seth S Martin; Parag H Joshi; John W McEvoy; Ty J Gluckman; Erin D Michos; Michael J Blaha; Roger S Blumenthal
Journal:  J Am Heart Assoc       Date:  2014-09-22       Impact factor: 5.501

10.  Evidence-Based Medicine in judicial decisions concerning right to healthcare.

Authors:  Eduardo Rocha Dias; Geraldo Bezerra da Silva Junior
Journal:  Einstein (Sao Paulo)       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.